Director, HEOR Strategy - Oncology
AbbVie
2 days ago
Remote friendly (Mettawa, IL)
United States
Market Access
Director, HEOR Strategy, CLL & Heme-Oncology (HEOR-S)
Responsibilities:
- Direct, develop, organize, and implement V&E strategy for CLL and disease adjacencies toward registration, PR&A, and market launch in compliance with national/international regulations.
- Co-create holistic value evidence strategy with V&E pillars and cross-functional partners (e.g., PCM deliverables, MHI Worldwide Scientific Plan, Value & Evidence Plans).
- Lead design, conduct, and analysis of multi-program projects; manage execution and budget; meet ethical, scientific, regulatory, commercial, and quality requirements.
- Communicate findings to internal/external stakeholders (e.g., HTAs/payers, patient advocacy groups, KOLs).
- Develop and execute V&E product life-cycle and labeling strategies post-marketing; integrate customer value-demonstration needs and science/commercial direction.
- Support commercialization via market access and market growth/defense; ensure end-to-end delivery of the V&E book of work.
- Partner to shape patient access policy and build external alliances; establish academic/community research partnerships.
Qualifications:
- MSc/MPH/MBA (10+ years) or PharmD/PhD (7+ years) in HEOR, market access, or related research.
- Deep HEOR expertise (modeling, PROs, statistics, RWE) with registry/observational experience.
- Proven oncology HEOR/market access across pipeline through lifecycle.
- Strong understanding of oncology commercialization; influencer in matrixed environments.
- Track record in HTA/value assessment with bodies such as NCCN, ESMO-MCBS, NICE, IQWiG, CADTH, MSAC, ICER.
- Experience with IDNs/GPOs and leading complex HEOR initiatives.
Benefits (explicit): paid time off; medical/dental/vision insurance; 401(k); long-term incentive program eligibility.
Responsibilities:
- Direct, develop, organize, and implement V&E strategy for CLL and disease adjacencies toward registration, PR&A, and market launch in compliance with national/international regulations.
- Co-create holistic value evidence strategy with V&E pillars and cross-functional partners (e.g., PCM deliverables, MHI Worldwide Scientific Plan, Value & Evidence Plans).
- Lead design, conduct, and analysis of multi-program projects; manage execution and budget; meet ethical, scientific, regulatory, commercial, and quality requirements.
- Communicate findings to internal/external stakeholders (e.g., HTAs/payers, patient advocacy groups, KOLs).
- Develop and execute V&E product life-cycle and labeling strategies post-marketing; integrate customer value-demonstration needs and science/commercial direction.
- Support commercialization via market access and market growth/defense; ensure end-to-end delivery of the V&E book of work.
- Partner to shape patient access policy and build external alliances; establish academic/community research partnerships.
Qualifications:
- MSc/MPH/MBA (10+ years) or PharmD/PhD (7+ years) in HEOR, market access, or related research.
- Deep HEOR expertise (modeling, PROs, statistics, RWE) with registry/observational experience.
- Proven oncology HEOR/market access across pipeline through lifecycle.
- Strong understanding of oncology commercialization; influencer in matrixed environments.
- Track record in HTA/value assessment with bodies such as NCCN, ESMO-MCBS, NICE, IQWiG, CADTH, MSAC, ICER.
- Experience with IDNs/GPOs and leading complex HEOR initiatives.
Benefits (explicit): paid time off; medical/dental/vision insurance; 401(k); long-term incentive program eligibility.